Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

By Rebecca Robbins from NYT Health https://ift.tt/SFPelHu
Prices (Fares, Fees and Rates), Inventions and Patents, Drugs (Pharmaceuticals), Health Insurance and Managed Care, Law and Legislation, Regulation and Deregulation of Industry, State Legislatures, Autoimmune Diseases, Insurance, Generic Brands and Products, Antitrust Laws and Competition Issues, Enbrel (Drug)